M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Middle East Pharmaceutical Industries Company SJSC
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Intangible Assets
ď·Ľ46.9m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Intangible Assets
ď·Ľ85.4m
CAGR 3-Years
23%
CAGR 5-Years
-4%
CAGR 10-Years
32%
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Intangible Assets
ď·Ľ13m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Middle East Pharmaceutical Industries Company SJSC
Glance View

Market Cap
2.4B SAR
Industry
Pharmaceuticals

Middle East Pharmaceutical Industries Company SJSC is a SA-based company operating in Pharmaceuticals industry. The company is headquartered in Riyadh, Riyadh and currently employs 335 full-time employees. The company went IPO on 2024-02-27. Middle East Pharmaceutical Industries Company SJSC is a Saudi Arabia-based pharmaceutical company. The firm develops, manufactures, markets, and distributes a wide range of generic medicines and pharmaceuticals. The Company’s activity is the manufacture of disinfectants and sterilizers for medical devices and products, the manufacture of disinfectants and sterilizers for non-medical use, the manufacture of cosmetics, and the manufacture of pharmaceutical preparations for human use.

Intrinsic Value
88.32 SAR
Overvaluation 27%
Intrinsic Value
Price
M

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Intangible Assets?
Intangible Assets
46.9m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Intangible Assets amounts to 46.9m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
19%

Over the last year, the Intangible Assets growth was 13%. The average annual Intangible Assets growth rates for Middle East Pharmaceutical Industries Company SJSC have been 19% over the past three years .

Back to Top